The World ADC San Diego 2026

Biointron is pleased to announce our participation in the 17th World ADC San Diego, taking place October 12–15, 2026, in San Diego, California. 

World ADC San Diego is one of the largest and longest-standing global forums dedicated to antibody-drug conjugates and the broader bioconjugate field. The program is designed to address ADC development from discovery through manufacturing, with seven dedicated content streams spanning discovery chemistry, discovery biology, preclinical development, translational medicine, clinical lessons, process and analytical development, and manufacturing and supply.  

As ADC pipelines become more competitive and technically sophisticated, high-quality antibody generation, expression, characterization, and developability assessment remain critical to selecting candidates with the right targeting, internalization, and manufacturability profiles. World ADC San Diego provides a valuable setting for Biointron to engage with teams advancing next-generation ADCs, bispecific ADCs, DACs, ISACs, AOCs, and other emerging conjugate formats. 

Biointron looks forward to connecting with ADC innovators, collaborators, and industry partners in San Diego and joining conversations that support the continued advancement of antibody-based conjugate therapeutics. 

For more details about the event, please visit the World ADC San Diego 2026 website [https://worldadc-usa.com/] 

Time: October 12 - 15, 2026 

Location: Town & Country Resort | San Diego, CA 

Booth: #112